Analysis of biological processes revealed that the FABP1 gene had significant involvement in “recurrent gene fusions in prostate cancer”, “transcription_FXR-regulated cholesterol and bile-acid cellular transport”, and “transcription_HIF-1 targets” in CRC development (Figure S2, Table S2). This evidence concerns the gene NR1H4 and prostate carcinoma.